PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Use it or lose it

Research illuminates a molecular mechanism for why a stimulating environment may protect against Alzheimer's Disease

2013-03-06
(Press-News.org) Boston, MA – "Use it or lose it." The saying could apply especially to the brain when it comes to protecting against Alzheimer's disease. Previous studies have shown that keeping the mind active, exercising and social interactions may help delay the onset of dementia in Alzheimer's disease.

Now, a new study led by Dennis Selkoe, MD, co-director of the Center for Neurologic Diseases in the BWH Department of Neurology, provides specific pre-clinical scientific evidence supporting the concept that prolonged and intensive stimulation by an enriched environment, especially regular exposure to new activities, may have beneficial effects in delaying one of the key negative factors in Alzheimer's disease.

The study will be published online on March 6, 2013 in Neuron.

Alzheimer's disease occurs when a protein called amyloid beta accumulates and forms "senile plaques" in the brain. This protein accumulation can block nerve cells in the brain from properly communicating with one another. This may gradually lead to an erosion of a person's mental processes, such as memory, attention, and the ability to learn, understand and process information.

The BWH researchers used a wild-type mouse model when evaluating how the environment might affect Alzheimer's disease. Unlike other pre-clinical models used in Alzheimer's disease research, wild-type mice tend to more closely mimic the scenario of average humans developing the disease under normal environmental conditions, rather than being strongly genetically pre-disposed to the disease.

Selkoe and his team found that prolonged exposure to an enriched environment activated certain adrenalin-related brain receptors which triggered a signaling pathway that prevented amyloid beta protein from weakening the communication between nerve cells in the brain's "memory center," the hippocampus. The hippocampus plays an important role in both short- and long-term memory.

The ability of an enriched, novel environment to prevent amyloid beta protein from affecting the signaling strength and communication between nerve cells was seen in both young and middle-aged wild-type mice.

"This part of our work suggests that prolonged exposure to a richer, more novel environment beginning even in middle age might help protect the hippocampus from the bad effects of amyloid beta, which builds up to toxic levels in one hundred percent of Alzheimer patients," said Selkoe.

Moreover, the scientists found that exposing the brain to novel activities in particular provided greater protection against Alzheimer's disease than did just aerobic exercise. According to the researchers, this observation may be due to stimulation that occurred not only physically, but also mentally, when the mice moved quickly from one novel object to another.

"This work helps provide a molecular mechanism for why a richer environment can help lessen the memory-eroding effects of the build-up of amyloid beta protein with age," said Selkoe. "They point to basic scientific reasons for the apparent lessening of AD risk in people with cognitively richer and more complex experiences during life."

### Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH has more than 3.5 million annual patient visits, is the largest birthing center in New England and employs more than 15,000 people. The Brigham's medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care, quality improvement and patient safety initiatives, and its dedication to research, innovation, community engagement and educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving nearly 1,000 physician-investigators and renowned biomedical scientists and faculty supported by nearly $625 million in funding. BWH continually pushes the boundaries of medicine, including building on its legacy in organ transplantation by performing the first face transplants in the U.S. in 2011. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies, OurGenes and the Women's Health Initiative. For more information and resources, please visit BWH's online newsroom.


ELSE PRESS RELEASES FROM THIS DATE:

1 region, 2 functions: Brain cells' multitasking key to understanding overall brain function

2013-03-06
A region of the brain known to play a key role in visual and spatial processing has a parallel function: sorting visual information into categories, according to a new study by researchers at the University of Chicago. Primates are known to have a remarkable ability to place visual stimuli into familiar and meaningful categories, such as fruit or vegetables. They can also direct their spatial attention to different locations in a scene and make spatially-targeted movements, such as reaching. The study, published in the March issue of Neuron, shows that these very different ...

KLAS Celebrates 15 Years of Best in KLAS with Healthcare VIPs

2013-03-06
KLAS Enterprises celebrated 15 years of working with providers and vendors last night with their annual Best in KLAS awards reception in New Orleans. The event was attended by prominent healthcare leaders who came to support KLAS' ongoing effort to improve healthcare transparency. The speakers for the evening included Jonathan Bush, CEO of athenahealth, Peter Smith, CEO and Co-Founder of Impact Advisors, and keynote speaker Russell Branzell, CEO of Colorado Health Medical Group. Branzell focused most of his comments on praising KLAS for being the "go-to source for ...

Health Care Providers Give Cloud Vendors High Marks on Security

2013-03-06
With an average satisfaction score of 4.5 out of 5 on security, cloud users feel safe. Non-cloud users though remain at bay--particularly with many questions still looming around the future of cloud computing in healthcare. The KLAS report titled Cloud Computing Perception 2013: The Hybrid Cloud in Healthcare looks at the evolution of the cloud in healthcare, provider concerns, as well as vendor performance. Given the near-perfect satisfaction scores that cloud-users gave to their vendors, 66% of non-users surveyed said security was definitely the main issue stopping ...

Resistance to first line anti-malarial drugs is increasing on the Thai-Myanmar border

2013-03-06
Early diagnosis and treatment with antimalarial drugs (ACTs—artemisinin based combination treatments) has been linked to a reduction in malaria in the migrant population living on the Thai-Myanmar border, despite evidence of increasing resistance to ACTs in this location, according to a study by international researchers published in this week's PLOS Medicine. These findings are important as this study suggests that alternative treatments are urgently needed to replace the failing first line drug regimen (mefloquine and artesunate). The authors, led by François Nosten ...

Sharing HIV research findings with participants

2013-03-06
Is it feasible to share research findings with HIV-infected participants enrolled in observational research in rural sub-Saharan African? Anna Baylor and colleagues orally disseminated their findings to 477 research participants during a meeting modelled on a traditional wedding event. The information was enthusiastically received by participants. The meeting was a rewarding experience for the research team and identified new areas for investigation, say the authors. ### Funding: The UARTO Study is funded by U.S. National Institutes of Health (NIH) RO-1 MH-54907 and ...

Use of certain therapies for inflammatory diseases does not appear to increase risk of shingles

2013-03-06
Although patients with rheumatoid arthritis (RA) have a disproportionately higher incidence of herpes zoster (shingles), an analysis that included nearly 60,000 patients with RA and other inflammatory diseases found that those who initiated anti-tumor necrosis factor therapies were not at higher risk of herpes zoster compared with patients who initiated nonbiologic treatment regimens, according to a study appearing in the March 6 issue of JAMA. "For patients with rheumatoid arthritis, the risk of herpes zoster is elevated an additional 2- to 3-fold. The contribution ...

Scarring of heart muscle linked with increased risk of death in patients with type of cardiomyopathy

2013-03-06
Detection of midwall fibrosis (the presence of scar tissue in the middle of the heart muscle wall) via magnetic resonance imaging among patients with nonischemic dilated cardiomyopathy (a condition affecting the heart muscle) was associated with an increased likelihood of death, according to a study appearing in the March 6 issue of JAMA. Nonischemic dilated cardiomyopathy is associated with significant illness and death due to progressive heart failure (HF) and sudden cardiac death (SCD). Despite therapeutic advances, 5-year mortality remains as high as 20 percent. ...

Study examines thinning of heart muscle wall among patients with coronary artery disease

2013-03-06
Among patients with coronary artery disease referred for cardiovascular magnetic resonance and found to have regional myocardial wall thinning (of the heart muscle), limited scar burden was associated with improved contraction of the heart and reversal of wall thinning after revascularization, suggesting that myocardial thinning is potentially reversible, according to a study appearing in the March 6 issue of JAMA. Regional myocardial wall thinning is thought to represent chronic myocardial infarction. "However, recent case reports incorporating the use of delayed-enhancement ...

New mechanism for relaxing airways using bitter tasting substances

2013-03-06
A team of scientists at the University of Massachusetts Medical School have found that substances which give some foods their bitter flavors can also act to reverse the contraction of airway cells. This reversal, known as bronchodilation, is needed to treat airway obstructive diseases such as asthma and chronic obstructive pulmonary disease. The new findings, which could have significant implications for such treatments, are published March 5 in the open access journal PLOS Biology. The sense of taste is mediated by taste receptor cells bundled in our taste buds. These ...

Safe, long-term opioid therapy is possible

2013-03-06
(Boston) – In a Clinical Crossroads article featured in the March 6, 2013 issue of the Journal of the American Medical Association (JAMA), Dr. Dan Alford from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) suggests that prescription opioid abuse can be minimized by monitoring patients closely for harm by using urine drug testing (UDT), pill counts, and reviewing prescription drug monitoring program data when available. Approximately 100 million Americans have chronic pain. The safe and effective use of opioids for the management of chronic ...

LAST 30 PRESS RELEASES:

Breaking free from dependence on rare resources! A domestic high-performance permanent magnet emerges!

Symptoms of long-COVID can last up to two years after infection with COVID-19

Violence is forcing women in Northern Ireland into homelessness, finds new report

Latin American intensivists denounce economic and cultural inequities in the global scientific publishing system

Older adults might be more resistant to bird flu infections than children, Penn research finds

Dramatic increase in research funding needed to counter productivity slowdown in farming

How chemistry and force etch mysterious spiral patterns on solid surfaces

Unraveling the mysteries of polycystic kidney disease

Mother’s high-fat diet can cause liver stress in fetus, study shows

Weighing in on a Mars water debate

Researchers ‘seq’ and find a way to make pig retinal cells to advance eye treatments

Re-purposed FDA-approved drug could help treat high-grade glioma

Understanding gamma rays in our universe through StarBurst

Study highlights noninvasive hearing aid 

NASA taps UTA to shape future of autonomous aviation

Mutations disrupt touch-based learning, study finds

Misha lived in zoos, but the elephant’s tooth enamel helps reconstruct wildlife migrations

Eat better, breathe easier? Research points to link between diet, lung cancer

Mesozoic mammals had uniform dark fur

Wartime destruction of Kakhovka Dam in Ukraine has long-term environmental consequences

NIH’s flat 15% funding policy is misguided and damaging

AI reveals new insights into the flow of Antarctic ice

Scientists solve decades-long Parkinson’s mystery

Spinning, twisted light could power next-generation electronics

A planetary boundary for geological resources: Limits of regional water availability

Astronomy’s dirty window to space

New study reveals young, active patients who have total knee replacements are unlikely to need revision surgery in their lifetime

Thinking outside the box: Uncovering a novel approach to brainwave monitoring

Combination immunotherapy before surgery may increase survival in people with head and neck cancer

MIT engineers turn skin cells directly into neurons for cell therapy

[Press-News.org] Use it or lose it
Research illuminates a molecular mechanism for why a stimulating environment may protect against Alzheimer's Disease